Author Archives: Fredricko
Intercept to Announce Third Quarter 2020 Financial Results on November 9, 2020
Go here to see the original:
Intercept to Announce Third Quarter 2020 Financial Results on November 9, 2020
Opiant Pharmaceuticals to Participate at the Jefferies 2020 Virtual London Healthcare Conference
Nabriva Therapeutics to Report Third Quarter 2020 Financial Results on November 5, 2020
MediWound to Report Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 10, 2020
Cara Therapeutics to Announce Third Quarter 2020 Financial Results on November 9, 2020
Continue reading here:
Cara Therapeutics to Announce Third Quarter 2020 Financial Results on November 9, 2020
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Pacific Biosciences of California, Inc. Announces Third Quarter 2020 Financial Results
Marrone Bio Innovations Appoints Lara L. Lee to Board of Directors
Read the original here:
Marrone Bio Innovations Appoints Lara L. Lee to Board of Directors
Entera Bio to Present at the H.C. Wainwright 6th Annual Israel Conference
See the article here:
Entera Bio to Present at the H.C. Wainwright 6th Annual Israel Conference
Neuronetics Reports Third Quarter 2020 Financial and Operating Results
Follow this link:
Neuronetics Reports Third Quarter 2020 Financial and Operating Results
Ascendis Pharma A/S Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 11
Trillium Therapeutics Appoints Dr. Ingmar Bruns as Chief Medical Officer
Go here to see the original:
Trillium Therapeutics Appoints Dr. Ingmar Bruns as Chief Medical Officer
Trillium Therapeutics Announces Formation of Scientific Advisory Board
Latest Wound Care Research from Organogenesis Highlighted at SAWC Fall 2020 Virtual Meeting
Satsuma Pharmaceuticals to to participate in the following November Virtual Investor Conferences
Syneos Health to Present at Upcoming Investor Conferences
Terranueva Announces Changes to Its Management Team
Excerpt from:
Terranueva Announces Changes to Its Management Team
Immutep’s TACTI-002 Data to Be Presented at Society for Immunotherapy of Cancer 2020 Annual Meeting
Go here to read the rest:
Immutep’s TACTI-002 Data to Be Presented at Society for Immunotherapy of Cancer 2020 Annual Meeting